Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07646782

Human Observatory Study

The Human Observatory Study is a prospective observational and ecological surveillance study building a continuously-updating world model for human health, disease, and death at the individual and population level. Individual multi-system clinical data from enrolled participants are linked to a continuously-ingested ecological data infrastructure spanning environmental exposures, social determinants, genealogical and family history records, mortality data, and population health databases at geographic resolutions from home address to global scale and beyond. The resulting model generates individual screening recommendations informed by population-level causal estimates, and population-level causal forecasts anchored by present-timepoint individual clinical biology. Thus creating a feedback architecture designed to improve both simultaneously.

Recruiting

Interested in participating?

Request Info

Key information

About this study

Existing approaches to human health prediction face a structural limitation: individual clinical studies measure biology without capturing the environment, while population epidemiology captures the environment without individual biological ground truth. The Human Observatory Study resolves this by operating at both levels simultaneously through a linked dual-layer architecture.

At the individual level, participants enrolled in the 100-Year Human Aging Study contribute comprehensive multi-system health measurements. This includes clinical, physiological, cognitive, behavioral, social, occupational, and environmental data collected at fixed and mobile clinical sites. These measurements provide the biological present timepoint that historical population data alone cannot supply.

At the population level, the Observatory continuously ingests ecological data from public and private registries across multiple input domains. This includes air quality, water and chemical contaminants, wildfire and smoke exposure, altitude and terrain, climate, satellite earth observation, occupational and industrial exposure, mortality and vital statistics, demographics and social determinants, and clinical data networks at geographic resolutions from home address to global scale and beyond. This ecological layer captures the environmental and social causal structure of health and disease continuously and does not require individual enrollment.

A foundational input domain is genealogy and family history. Health and disease run in families across generations. The Observatory is designed to build and continuously expand a linked genealogical database connecting living and historical individuals to their family health histories. Information is obtained from public genealogical records, death registries, family history self-report, and genetic data where available. The long-term vision is a genealogical infrastructure of sufficient depth and breadth to trace familial health patterns across the full recorded human family tree. Therefore connecting individual present-timepoint biology to multigenerational patterns of disease, longevity, and environmental exposure that no existing biobank or longitudinal study has attempted to capture at this scale.

The linked architecture enables a feedback loop with two outputs: population-level causal estimates that inform individual screening recommendations, and individual clinical data that give population models a present biological anchor for prospective forecasting. The degree to which each input domain, alone and in combination, predicts health, disease, and death across geographic scales from neighborhood to global and beyond is the central scientific question the Observatory is designed to answer.

The Observatory launches in Colorado, chosen as the founding site for its exceptional natural variation in altitude, wildfire smoke corridors, mining and industrial chemical geographies, and frontier-to-urban socioeconomic gradient all within a compact, well-characterized geography with established academic research infrastructure. Colorado proves the model. The architecture then replicates geographically, with each new location enriching the world model for every other. The long-term vision is global coverage and beyond. Every geography will contribute its environmental, social, and biological signal to a world model that gets more accurate with every geography studied, every participant enrolled, every dataset ingested, and every causal analysis conducted.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Enrolled in the 100-Year Human Aging Study at any fixed or mobile clinical site; OR completion of online health screener with provision of geographic anchor data and consent.

Exclusion criteria

  • Age under 18 years (current protocol; pediatric amendment planned).

Treatment and study plan

Multi-Domain Ecological and Clinical Data Linkage

Other

Linkage of individual multi-system clinical health measurements to continuously-ingested ecological data from public and private registries spanning environmental, social, genealogical, and population health domains at geographic resolutions from home address to global scale and beyond. The linked dataset feeds a continuously-updating causal inference engine generating life expectancy estimates, disease cluster detection, individual screening recommendations, and population health intelligence.

Primary outcomes

  1. Life Expectancy Estimates by Geography

    Time frame: From enrollment until death, assessed periodically, up to 100 years

    Continuously-updated life expectancy point estimates with credible intervals generated at individual, neighborhood, ZIP code, county, state, national, global, and beyond-earth scales using individual clinical data linked to population mortality records, environmental context, and ecological data.

  2. Geographic Disease Cluster and Outbreak Detection

    Time frame: From enrollment until death, assessed periodically, up to 100 years

    Statistically anomalous concentrations of incident disease, mortality spikes, or shared symptom patterns at neighborhood and community resolution.

Secondary outcomes

  1. Individual Screening Recommendation Accuracy

    Time frame: From enrollment until death, assessed periodically, up to 100 years

    Concordance between population-level causal estimates used to generate individualized screening recommendations and actual individual health outcomes at longitudinal follow-up, assessed periodically as outcomes accrue.

  2. Causal Effect Estimates for Modifiable Exposures

    Time frame: From enrollment until death, assessed periodically, up to 100 years

    Estimated attributable life-years gained or lost per unit change in modifiable environmental, occupational, and social exposures.

  3. Geographic Variation in Disability-Free Life Expectancy

    Time frame: From enrollment until death, assessed periodically, up to 100 years

    Disability-free life expectancy stratified by geography, ascertained via the functional independence and disability survey instrument used across all three associated protocols.

  4. Health Equity Characterization

    Time frame: From enrollment until death, assessed periodically, up to 100 years

    Life expectancy gaps and chronic disease disparities stratified by geography, income, race and ethnicity, educational attainment, and rural-urban classification.

  5. Human Tree of Life Growth

    Time frame: From enrollment until death, assessed periodically, up to 100 years

    Total participants linked to genealogical record; multigenerational depth achieved; proportion of enrolled participants with identified biological relatives in the registry; total historical individuals linked across all genealogical databases.

  6. Population Biological Age Acceleration

    Time frame: From enrollment until death, assessed periodically, up to 100 years

    Mean difference between chronological age and biological age estimate for repeat-visit participants, stratified by geographic and demographic characteristics.

  7. Multi-Domain Predictor Modeling

    Time frame: From enrollment until death, assessed periodically, up to 100 years

    Assessment of individual and composite clinical, biological, behavioral, environmental, social, occupational, genealogical, and geographic measurements as predictors of all-cause mortality, life expectancy, and incident serious disease at population scale; analyses evaluate which domains are independently predictive, which are redundant, and which combinations provide additive or synergistic predictive value.

  8. Incident Serious Health Events and Chronic Disease

    Time frame: From enrollment until death, assessed periodically, up to 100 years

    New diagnosis of myocardial infarction, stroke, cancer, dementia, heart failure, atrial fibrillation, sepsis, venous thromboembolism, COPD, chronic hypoxia, major fracture, type 2 diabetes, hypertension, COPD, chronic kidney disease, metabolic syndrome, or osteoporosis ascertained via periodic follow-up contact and health data network linkage.

Study contacts

Contact information is provided by the study sponsor or research team.

William Brandenburg, MD

CONTACT

[email protected]

13035010016

Sponsors and collaborators

Lead sponsor

Longevity Metrics, Inc.

Industry

Registry information

Official study title

The Human Observatory: A Prospective Individual and Population-Level Study of Aging, Health, and Longevity

Acronym: HOS

Important dates

Study start
2026
Primary completion
2099
Study completion
2099
First posted
Jun 15, 2026
Registry last updated
Jun 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.